IL15 and cancer: IL-15 proves to be a promising candidate for cancer immunotherapy due to its functional similarity to IL-2 with several added benefits, including the lack of stimulation on regulatory T cell populations, reduced activation-induced cell death (AICD), and lower toxicity [33] (Table 2).